Northwestern Mutual Wealth Management CO Tg Therapeutics, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $112 Billion
- Q3 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 20,025 shares of TGTX stock, worth $646,006. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,025
Previous 19,300
3.76%
Holding current value
$646,006
Previous $343,000
36.44%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TGTX
# of Institutions
338Shares Held
87.7MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$496 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$367 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$293 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$116 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$103 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.69B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...